CA3232213A1 - Drug conjugates of sugar derivatives and uses thereof as senolytic agents - Google Patents
Drug conjugates of sugar derivatives and uses thereof as senolytic agents Download PDFInfo
- Publication number
- CA3232213A1 CA3232213A1 CA3232213A CA3232213A CA3232213A1 CA 3232213 A1 CA3232213 A1 CA 3232213A1 CA 3232213 A CA3232213 A CA 3232213A CA 3232213 A CA3232213 A CA 3232213A CA 3232213 A1 CA3232213 A1 CA 3232213A1
- Authority
- CA
- Canada
- Prior art keywords
- compound
- disease
- diseases
- residue
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/549—Sugars, nucleosides, nucleotides or nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/18—Acyclic radicals, substituted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163243539P | 2021-09-13 | 2021-09-13 | |
| US63/243,539 | 2021-09-13 | ||
| PCT/US2022/076360 WO2023039600A1 (en) | 2021-09-13 | 2022-09-13 | Drug conjugates of sugar derivatives and uses thereof as senolytic agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3232213A1 true CA3232213A1 (en) | 2023-03-16 |
Family
ID=85507744
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3232213A Pending CA3232213A1 (en) | 2021-09-13 | 2022-09-13 | Drug conjugates of sugar derivatives and uses thereof as senolytic agents |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US20230137021A1 (https=) |
| EP (1) | EP4380575A4 (https=) |
| JP (1) | JP2024533426A (https=) |
| CN (1) | CN118475356A (https=) |
| AU (1) | AU2022342245A1 (https=) |
| CA (1) | CA3232213A1 (https=) |
| WO (1) | WO2023039600A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023039292A2 (en) * | 2021-09-13 | 2023-03-16 | Rubedo Life Sciences, Inc. | Novel sugar derivatives and uses thereof to prepare novel senolytic agents |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2710322T3 (es) * | 2012-08-28 | 2019-04-24 | Univ Tuebingen Medizinische Fakultaet | Trazadores de la senescencia |
| IL286427B2 (en) * | 2014-01-28 | 2024-08-01 | Mayo Found Medical Education & Res | Inhibitors bcl-2 anti-apoptotic protein family members for treatment of non cancer pulmonary disease or an opthalmic disease |
| US20210180013A1 (en) * | 2018-04-23 | 2021-06-17 | Agex Therapeutics, Inc. | Improved methods for inducing tissue regeneration and senolysis in mammalian cells |
| US11026963B2 (en) * | 2018-07-11 | 2021-06-08 | Rubedo Life Sciences, Inc. | Senolytic compositions and uses thereof |
-
2022
- 2022-09-13 EP EP22868391.8A patent/EP4380575A4/en active Pending
- 2022-09-13 US US17/943,824 patent/US20230137021A1/en not_active Abandoned
- 2022-09-13 CA CA3232213A patent/CA3232213A1/en active Pending
- 2022-09-13 AU AU2022342245A patent/AU2022342245A1/en active Pending
- 2022-09-13 WO PCT/US2022/076360 patent/WO2023039600A1/en not_active Ceased
- 2022-09-13 JP JP2024515577A patent/JP2024533426A/ja active Pending
- 2022-09-13 CN CN202280072208.7A patent/CN118475356A/zh active Pending
-
2024
- 2024-05-06 US US18/655,834 patent/US20240299555A1/en active Pending
-
2025
- 2025-02-10 US US19/049,614 patent/US20250222115A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2023039600A1 (en) | 2023-03-16 |
| AU2022342245A1 (en) | 2024-03-28 |
| JP2024533426A (ja) | 2024-09-12 |
| EP4380575A4 (en) | 2025-07-23 |
| US20250222115A1 (en) | 2025-07-10 |
| EP4380575A1 (en) | 2024-06-12 |
| CN118475356A (zh) | 2024-08-09 |
| US20230137021A1 (en) | 2023-05-04 |
| US20240299555A1 (en) | 2024-09-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102843318B1 (ko) | 세놀리틱 조성물 및 이의 사용 | |
| US20250222115A1 (en) | Drug Conjugates of Sugar Derivatives and Uses Thereof as Senolytic Agents | |
| US20260007689A1 (en) | GPX4 Inhibitors and Senolytic Compounds and Uses Thereof | |
| EP2382206A2 (en) | Compounds and methods for the treatment of pain and other diseases | |
| CA3105982C (en) | Senolytic compositions and uses thereof | |
| WO2025199126A1 (en) | Gpx4 inhibitors and senolytic compounds and uses thereof | |
| WO2025117556A1 (en) | Phosphorous containing bcl inhibitors and senolytic compounds and uses thereof | |
| US20250171435A1 (en) | Carbon Linked BCL Inhibitors and Senolytic Compounds and Uses Thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 2ND ANNIV.) - STANDARD Year of fee payment: 2 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20240906 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT Effective date: 20240906 Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20240906 |
|
| P22 | Classification modified |
Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P22-P110 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CLASSIFICATION MODIFIED Effective date: 20240925 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 3RD ANNIV.) - STANDARD Year of fee payment: 3 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20250905 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250909 |